ArticleBMC medicine2024

IL-2-free tumor-infiltrating lymphocyte therapy with PD-1 blockade demonstrates potent efficacy in advanced gynecologic cancer.

Jing Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.